Ipratropium bromide, sold under the trade name Atrovent among others, is a medication that opens up the medium and large airways in the lungs(支气管扩张药).[1] It is used to treat the symptoms of chronic obstructive pulmonary disease(慢性阻塞性肺病) and asthma(哮喘). It is used byinhaler(3) or nebulizer(13). Onset of action is typically within 15 to 30 minutes and lasts for three to five hours.[1]
’’’異丙托溴銨’’’（{{lang|en|Ipratropium bromide}}），常見商品名=
Common side effects include dry mouth, cough, and inflammation of the airways(支气管炎). Potentially serious side effects include urinary retention(尿瀦留), worsening spasms of the airways, and a severe allergic reaction(全身型過敏性反應).[1] It appears to be safe in pregnancy(妊娠) andbreastfeeding(母乳餵養).[1][2] Ipratropium is an anticholinergic(抗膽鹼劑)which works by causing smooth muscles(平滑肌) to relax.[1]
Ipratropium bromide was developed in Germany in 1976.[3] It was approved for medical use in the United States in 1986.[1] It is on the World Health Organization’s List of Essential Medicines(世界卫生组织基本药物标准清单), the most important medication needed in a basic health system(13).[4]Ipratropium is available as a generic medication.[1] The wholesale price is about 6.60 USD for a 200 dose inhaler.[5] In the United States a month worth of medication is between 100 and 200 USD.[6]